Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Narcolepsy Therapeutics Market
Narcolepsy Therapeutics Market Size
- Report ID: GMI10260
- Published Date: Jul 2024
- Report Format: PDF
Narcolepsy Therapeutics Market Size
Narcolepsy Therapeutics Market was valued at around USD 3.6 billion in 2023 and is estimated to grow at 8.2% CAGR from 2024 to 2032. The increasing prevalence of narcolepsy is a major factor driving the growth of the market. Narcolepsy, a chronic sleep disorder characterized by excessive daytime sleepiness and sudden muscle weakness (cataplexy), affects approximately 1 in 2,000 individuals in the U.S.
Narcolepsy therapeutics refer to the treatments and medications used to manage narcolepsy, a chronic sleep disorder characterized by excessive daytime sleepiness, sudden loss of muscle tone (cataplexy), sleep paralysis, and hallucinations. The goal of these therapies is to alleviate the symptoms, improve wakefulness, and enhance the quality of life for individuals with narcolepsy.
| Report Attribute | Details |
|---|---|
| Base Year: | 2023 |
| Narcolepsy Therapeutics Market Size in 2023: | USD 3.6 Billion |
| Forecast Period: | 2024 - 2032 |
| Forecast Period 2024 - 2032 CAGR: | 8.2% |
| 2032 Value Projection: | USD 7.3 Billion |
| Historical Data for: | 2021 - 2023 |
| No. of Pages: | 100 |
| Tables, Charts & Figures: | 118 |
| Segments covered: | Disease Type, Treatment Type, Distribution Channel and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Narcolepsy Therapeutics Market Scope
